Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Eur J Obstet Gynecol Reprod Biol ; 245: 19-25, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31821921

RESUMEN

INTRODUCTION: To determine a minimum threshold of medical staffing needs (obstetricians-gynecologists, anesthesiologists-resuscitation specialists, nurse-anesthetists, pediatricians, and midwives) to ensure the safety and quality of care for unscheduled obstetrics-gynecology activity. MATERIALS AND METHODS: Face to face meetings of French healthcare professionals involved in perinatal care in different types of practices (academic hospital, community hospital or private practice) who belong to French perinatal societies: French National College of Gynecologists-Obstetricians (CNGOF), the French Society of Anesthesia and Resuscitation Specialists (SFAR), the French Society of Neonatology (SFN), the French Society of Perinatal Medicine (SFMP), the National College of French Midwives (CNSF), and the French Federation of Perinatal Care Networks (FFRSP). RESULTS: Different minimum thresholds for each category of care provider were proposed according to the number of births/year in the facility. These minimum thresholds can be modulated upwards as a function of the level of care (Level 1, 2 or 3 for perinatal centers), existence of an emergency department, and responsibilities as a referral center for maternal-fetal and/or surgical care. For example, an obstetrics-gynecology department handling 3000-4500 births per year without serving as a referral center must have an obstetrician-gynecologist, an anesthesiologist-resuscitation specialist, a nurse-anesthetist, and a pediatrician onsite specifically to provide care for unscheduled obstetrics-gynecology needs and a second obstetrician-gynecologist available within a time compatible with security requirements 24/7; the number of midwives always present (24/7) onsite and dedicated to unscheduled care is 5.1 for 3000 births and 7.2 for 4500 births. A maternity unit's occupancy rate must not exceed 85 %. CONCLUSION: The minimum thresholds proposed here are intended to improve the safety and quality of care of women who require unscheduled care in obstetrics-gynecology or during the perinatal period.


Asunto(s)
Servicios Médicos de Urgencia/provisión & distribución , Ginecología/métodos , Fuerza Laboral en Salud/estadística & datos numéricos , Obstetricia/métodos , Admisión y Programación de Personal/estadística & datos numéricos , Atención a la Salud/normas , Atención a la Salud/estadística & datos numéricos , Servicios Médicos de Urgencia/normas , Femenino , Francia , Ginecología/normas , Humanos , Partería/métodos , Partería/normas , Obstetricia/normas , Admisión y Programación de Personal/normas , Embarazo , Mejoramiento de la Calidad
2.
Therapie ; 72(3): 339-343, 2017 Jun.
Artículo en Francés | MEDLINE | ID: mdl-27863774

RESUMEN

Many trials have shown that folic acid supplementation before and during pregnancy reduces the risk of neural tube defects in general population. We investigated the knowledge of folic acid in women of child-bearing age. Women of child-bearing age were interviewed by 20 pharmacists living in Haute-Garonne between January and February 2014. One hundred ninety-six women were included in the present study. Out of them, 36% of women never heard of folic acid and 82% were not aware of its benefits. Knowledge was higher in older women, women in a couple and women with higher educational level (P<10-2). This study underlines that women are not enough aware of benefits of folic acid during pregnancy. Moreover, previous studies have shown that French women have low use of folic acid during peri-conceptional period. Information of general population will be required for a better prevention of folic acid-preventable NTDs.


Asunto(s)
Ácido Fólico , Conocimientos, Actitudes y Práctica en Salud , Complejo Vitamínico B , Adulto , Suplementos Dietéticos , Femenino , Francia , Humanos , Entrevistas como Asunto , Defectos del Tubo Neural/prevención & control , Embarazo
3.
FEMS Microbiol Ecol ; 92(10)2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27387912

RESUMEN

The increasing accessibility to navigation and offshore oil exploration brings risks of hydrocarbon releases in Arctic waters. Bioremediation of hydrocarbons is a promising mitigation strategy but challenges remain, particularly due to low microbial metabolic rates in cold, ice-covered seas. Hydrocarbon degradation potential of ice-associated microbes collected from the Northwest Passage was investigated. Microcosm incubations were run for 15 days at -1.7°C with and without oil to determine the effects of hydrocarbon exposure on microbial abundance, diversity and activity, and to estimate component-specific hydrocarbon loss. Diversity was assessed with automated ribosomal intergenic spacer analysis and Ion Torrent 16S rRNA gene sequencing. Bacterial activity was measured by (3)H-leucine uptake rates. After incubation, sub-ice and sea-ice communities degraded 94% and 48% of the initial hydrocarbons, respectively. Hydrocarbon exposure changed the composition of sea-ice and sub-ice communities; in sea-ice microcosms, Bacteroidetes (mainly Polaribacter) dominated whereas in sub-ice microcosms, the contribution of Epsilonproteobacteria increased, and that of Alphaproteobacteria and Bacteroidetes decreased. Sequencing data revealed a decline in diversity and increases in Colwellia and Moritella in oil-treated microcosms. Low concentration of dissolved organic matter (DOM) in sub-ice seawater may explain higher hydrocarbon degradation when compared to sea ice, where DOM was abundant and composed of labile exopolysaccharides.


Asunto(s)
Biodegradación Ambiental , Hidrocarburos/metabolismo , Cubierta de Hielo/microbiología , Contaminación por Petróleo , Contaminantes Químicos del Agua/metabolismo , Alphaproteobacteria/genética , Regiones Árticas , Bacteroidetes/genética , Canadá , Flavobacteriaceae/genética , Nunavut , Petróleo/metabolismo , ARN Ribosómico 16S/genética , Agua de Mar/microbiología
4.
Therapie ; 63(2): 135-40, 2008.
Artículo en Francés | MEDLINE | ID: mdl-18561888

RESUMEN

OBJECTIVES: Spa therapy is often considered as a dedicated period for a global treatment of patients. However, the prescription behaviours of spa physicians remain largely unknown. METHODS: A postal questionnaire concerning drug prescriptions during spa therapy and occurrence of adverse reactions to spa therapy was sent to the 95 spa physicians of South West of France. RESULTS: Seventy physicians answered to the survey. During spa period, most of them (67%) could associate drug prescription in complement of spa therapy. Drugs most often prescribed were analgesic (80%), non steroidal anti-inflammatory (57%) and antiinfectious (37%) drugs. Fifty nine per cent of the spa physicians could suppress part of the usual drug treatment of the patients. Spa related drugs which were the most often suppressed were anti-arthrosic and veinotonic drugs. Spa physicians could also modify or suppress drugs unrelated to the purpose of spa therapy, mainly psychotropics (anxiolytics or hypnotics), statins, diuretics or hypoglycemics (in case of inefficacy or adverse drug reactions). Spa physicians modified more drug prescriptions related to spa therapy than those unrelated to the purpose of spa therapy. Most of the spa physicians (77%) did observe adverse reactions to spa treatments. For 53% of the physicians, these adverse reactions could be "serious". The 2007 results were compared to those obtained during a similar survey performed 20 years before (1987). CONCLUSION: Spa therapy is often associated with change in drug prescriptions, with mainly a decrease in the number of prescribed drugs. Adverse reactions to spa therapy are rare and mainly "unserious". However, their imputability remains difficult to establish, thus justifying the need of a specific vigilance in spa therapy ("SpaVigilance").


Asunto(s)
Prescripciones de Medicamentos/estadística & datos numéricos , Hidroterapia , Utilización de Medicamentos , Francia/epidemiología , Humanos , Médicos , Vigilancia de Productos Comercializados , Encuestas y Cuestionarios
5.
Pharmacoepidemiol Drug Saf ; 13(10): 711-5, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15386730

RESUMEN

PURPOSE: The aim of the present study was to determine whether community pharmacists recommend appropriate medications and give valid information to pregnant women. METHODS: A total of 163 community pharmacists randomly selected in the Midi-Pyrénées area were interviewed by means of an open questionnaire. Ten scenarios were proposed concerning back pain, headache, coughs and sore-throats, fever, constipation, nausea, dyspepsia, 'venous insufficiency', allergic rhinitis and insomnia. RESULTS: Out of the total, 130 pharmacists accepted to answer. Out of them 94.5% reported advising homeopathy, especially for coughs and allergy. They often advised medication for pain, fever, nose and oropharynx disorders, 'venous insufficiency', dyspepsia or constipation. By contrast, they referred the women to the general practitioner for nausea and vomiting or back pain. Advice without drug dispensation was given for gastrointestinal disorders or 'venous insufficiency'. Phytotherapy only concerned 0.5-2% of the answers except for anxiety and sleep disturbances (59%), 'venous disorders'(17%) and sore-throat (9%). Pharmacists' answers were sometimes inappropriate involving (1) pharmacologically illogical advice, (2) drugs for which neither clinical nor experimental data are available and (3) drugs potentially harmful in pregnancy. CONCLUSIONS: The present study shows that French community pharmacists do not always give appropriate advice to pregnant women. As primary health care providers, pharmacists have to improve counselling regarding drug use in pregnancy.


Asunto(s)
Servicios Comunitarios de Farmacia , Consejo , Servicios de Información sobre Medicamentos , Feto/efectos de los fármacos , Farmacéuticos , Femenino , Humanos , Masculino , Embarazo , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA